Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000254839 | SCV000321613 | pathogenic | not provided | 2021-10-27 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11391482, 10713884, 26239617, 24532482, 19810120, 23439489, 9521425, 11170095, 26961984, 25468659, 33414810, 30334991, 30806661, 34006472, 33552269) |
Invitae | RCV000630812 | SCV000751779 | pathogenic | Multiple congenital exostosis | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 340 of the EXT1 protein (p.Arg340His). This variant is present in population databases (rs119103287, gnomAD 0.0009%). This missense change has been observed in individual(s) with hereditary multiple osteochondromas, also known as hereditary multiple exostoses (PMID: 9521425, 10713884, 19810120, 23439489, 24532482, 25468659, 26239617, 26961984). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 265129). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EXT1 protein function. Experimental studies have shown that this missense change affects EXT1 function (PMID: 11391482). For these reasons, this variant has been classified as Pathogenic. |
3billion | RCV001263553 | SCV002521833 | pathogenic | Exostoses, multiple, type 1 | 2022-05-22 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Protein truncation variants are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.78). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000265129). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID:19810120). Different missense changes at the same codon (p.Arg340Cys, p.Arg340Gly, p.Arg340Leu) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002495, VCV000002500, VCV000988576). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Institute for Clinical Genetics, |
RCV000254839 | SCV004026144 | pathogenic | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | PP4, PP5, PS4, PM2_SUP, PP1 |
OMIM | RCV001263553 | SCV001441614 | pathogenic | Exostoses, multiple, type 1 | 2020-11-06 | no assertion criteria provided | literature only | |
Beijing Key Laboratory for Genetic Research of Skeletal Deformity, |
RCV000630812 | SCV001482330 | pathogenic | Multiple congenital exostosis | 2019-05-31 | no assertion criteria provided | research |